The National Agency for Food and Drug Administration and Control (NAFDAC), has debunked reports in some sections of the media indicating that the agency has banned the use of Amoxicillin in Nigeria.
NAFDAC called on the public to disregard the information which it described as “false.”
In a statement issued in Abuja on Monday by the Director General, Prof. Mojisola Adeyeye, she explained that “NAFDAC has not banned Amoxicillin” in Nigeria.
The DG, however explained that:
“In recent months, NAFDAC issued targeted safety alerts on certain brands and batches of Amoxicillin. In August 2025, Public alert No. 24/2025 announced the recall of Amoxivue (Amoxicillin) 500mg capsules due to low Active Pharmaceutical ingredient (API) content . In October 2025, Public Alert No. 34/2025 addressed substandard batches of Astamocil and Astamentin suspensions, while Public Alert No. 35/2025 notified the public of standard batches of Annkox and Jawamox suspensions . These actions were specific to identified products and do not constitute a ban on Amoxicillin.”
NAFDAC, therefore “urge[d] the public, healthcare professionals, and stakeholders to disregard the misinformation and rely only on verified updates published on NAFDAC’s official channels.”
